164 related articles for article (PubMed ID: 25589798)
1. Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfalls.
Santra A; Kumar R; Sharma P
Indian J Nucl Med; 2015; 30(1):1-8. PubMed ID: 25589798
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m Glucoheptonate Single Photon Emission Computed Tomography-Computed Tomography for Detection of Recurrent Glioma: A Prospective Comparison with N-13 Ammonia Positron Emission Tomography-Computed Tomography.
Khangembam BC; Singhal A; Kumar R; Bal C
Indian J Nucl Med; 2019; 34(2):107-117. PubMed ID: 31040521
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation.
Barai S; Rajkamal ; Bandopadhayaya GP; Pant GS; Haloi AK; Malhotra A; Dhanpathi H
J Clin Neurosci; 2005 Jan; 12(1):27-31. PubMed ID: 16568553
[TBL] [Abstract][Full Text] [Related]
4. Role of Tc-glucoheptonic acid brain single photon emission computed tomography in differentiation of recurrent brain tumour and post-radiation gliosis.
Barai S; Bandopadhayaya GP; Julka PK; Naik KK; Haloi AK; Kumar R; Seith A; Malhotra A
Australas Radiol; 2004 Sep; 48(3):296-301. PubMed ID: 15344976
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Technetium-99m glucoheptonate single photon emission computed tomography for brain tumor grading.
Alam SS; Junaid S; Ahmed SM
Asian J Neurosurg; 2016; 11(2):118-28. PubMed ID: 27057217
[TBL] [Abstract][Full Text] [Related]
6. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrence in glioma: a comparative prospective study between Tc-99m GHA SPECT and F-18 FDG PET/CT.
Santra A; Kumar R; Sharma P; Bal C; Julka PK; Malhotra A
Clin Nucl Med; 2011 Aug; 36(8):650-5. PubMed ID: 21716014
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glucoheptonate single photon emission computed tomography and contrast-enhanced MRI in detection of recurrent glioma.
Santra A; Sharma P; Kumar R; Bal C; Kumar A; Julka PK; Malhotra A
Nucl Med Commun; 2011 Mar; 32(3):206-11. PubMed ID: 21224746
[TBL] [Abstract][Full Text] [Related]
9. Imaging of recurrent brain tumors with trivalent (99m)Tc-dimercaptosuccinic acid - initial results.
Barai S; Bandopadhayaya G; Julka P; Malhotra A; Naik K; Haloi A; Seith A; Halanaik D
Hell J Nucl Med; 2004; 7(1):44-7. PubMed ID: 16868641
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m glucoheptonate is poor man's fluorodeoxyglucose.
Lele RD
Indian J Nucl Med; 2011 Oct; 26(4):165-70. PubMed ID: 23559709
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of renal concentration of technetium-99m glucoheptonate.
Lee HB; Blaufox MD
J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
[TBL] [Abstract][Full Text] [Related]
12. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
13. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
[TBL] [Abstract][Full Text] [Related]
14. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
[TBL] [Abstract][Full Text] [Related]
15. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
Amin A; Moustafa H; Ahmed E; El-Toukhy M
J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intracranial space-occupying lesion with Tc99m-glucoheptonate brain single photon emission computed tomography in treatment-naïve patients.
Jaiswal S; Barai S; ; Gambhir S; Ora M; Mahapatra AK
J Postgrad Med; 2009; 55(3):180-4. PubMed ID: 19884742
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
19. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images.
Shih WJ; Lee JK; Milan P
J Nucl Med; 1996 Jul; 37(7):1183-5. PubMed ID: 8965195
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Diagnostic Efficacy of
Kumar P; Kumar A; Nagaraj C; Sadashiva N; Saini J; Mangalore S; Rajan A; Sitani K; Beniwal M; Santosh V; Basavaraja H; Hazari PP; Mishra AK
Cancer Biother Radiopharm; 2024 Feb; ():. PubMed ID: 38324045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
